GGrantIndex
← Leaderboards

Patrick W Mantyh

University Of Minnesota Twin Cities

$11,925,401
Attributed
$11,925,401
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200519
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$11,925,401 · 7

By mechanism

R01$9,066,217 · 5
R37$2,858,386 · 1
T32$798 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Minnesota Twin Cities

Same institution · by research overlap

Others in their field

Top investigators on “Analgesics

Research focus

AnalgesicsSensoryPainNerve FibersQuality Of LifeCancer PainBaseFunctional StatusAutomobile DrivingNervePlayBoneCapsaicinPeripheralMorphineNociceptorsAnimalsAfferent NerveBone PainFemurChronic PainInjection Of Therapeutic AgentNeuronsAttenuated

Grant awards (40)

Peripheral Nociceptors in Persistent Pain$427,630
R01 · FY2019 · NS · contact PI
Peripheral Nociceptors in Persistent Pain$427,630
R01 · FY2018 · NS · contact PI
Peripheral Nociceptors in Persistent Pain$427,630
R01 · FY2017 · NS · contact PI
Peripheral Nociceptors in Persistent Pain$427,397
R01 · FY2016 · NS · contact PI
Peripheral Nociceptors in Persistent Pain$478,165
R01 · FY2015 · NS · contact PI
METASTATIC PROSTATE CANCER-INDUCED BONE PAIN$314,363
R01 · FY2015 · CA · contact PI
Preventive Analgesia for Bone Cancer Pain$314,363
R01 · FY2015 · CA · contact PI
METASTATIC PROSTATE CANCER-INDUCED BONE PAIN$304,932
R01 · FY2014 · CA · contact PI
Preventive Analgesia for Bone Cancer Pain$304,932
R01 · FY2014 · CA · contact PI
Preventive Analgesia for Bone Cancer Pain$98,973
R01 · FY2014 · CA · contact PI
METASTATIC PROSTATE CANCER-INDUCED BONE PAIN$295,501
R01 · FY2013 · CA · contact PI
Preventive Analgesia for Bone Cancer Pain$295,501
R01 · FY2013 · CA · contact PI
Peripheral Nociceptors in Persistent Pain$324,778
R01 · FY2012 · NS · contact PI
METASTATIC PROSTATE CANCER-INDUCED BONE PAIN$314,363
R01 · FY2012 · CA · contact PI
Preventive Analgesia for Bone Cancer Pain$314,363
R01 · FY2012 · CA · contact PI
Peripheral Nociceptors in Persistent Pain$324,778
R01 · FY2011 · NS · contact PI
Preventive Analgesia for Bone Cancer Pain$314,363
R01 · FY2011 · CA · contact PI
METASTATIC PROSTATE CANCER-INDUCED BONE PAIN$314,363
R01 · FY2011 · CA · contact PI
Peripheral Nociceptors in Persistent Pain$327,822
R01 · FY2010 · NS · contact PI
Peripheral Nociceptors in Persistent Pain$330,313
R01 · FY2009 · NS · contact PI
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$257,088
R37 · FY2007 · NS · contact PI
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$184,632
R37 · FY2007 · NS · contact PI
Cancer Pain and Breast Tumor Metastasis to Bone$163,049
R01 · FY2007 · NS · contact PI
Cancer Pain and Breast Tumor Metastasis to Bone$130,001
R01 · FY2007 · NS · contact PI
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$436,993
R37 · FY2006 · NS · contact PI
Cancer Pain and Breast Tumor Metastasis to Bone$301,802
R01 · FY2006 · NS · contact PI
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$424,779
R37 · FY2005 · NS
Cancer Pain and Breast Tumor Metastasis to Bone$309,066
R01 · FY2005 · NS
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$402,801
R37 · FY2004 · NS
Cancer Pain and Breast Tumor Metastasis to Bone$309,066
R01 · FY2004 · NS
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$393,230
R37 · FY2003 · NS
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$383,941
R37 · FY2002 · NS
NEUROCHEMISTRY OF NOCICEPTION$329,946
R01 · FY2002 · DA
NEUROCHEMISTRY OF NOCICEPTION$321,702
R01 · FY2001 · DA
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$300,672
R37 · FY2001 · NS
PERIPHERAL NOCICEPTORS IN PERSISTENT PAIN$74,250
R37 · FY2001 · NS
MINNESOTA PAIN RESEARCH TRAINING PROGRAM$5
T32 · FY2001 · DE
NEUROCHEMISTRY OF NOCICEPTION$313,697
R01 · FY2000 · DA
PERIPHERAL NOCICEPTORS IN INFLAMMATION$205,728
R01 · FY2000 · NS
MINNESOTA PAIN RESEARCH TRAINING PROGRAM$793
T32 · FY2000 · DE